4/A

PRIMARY DOCUMENT

Company: Dianthus Therapeutics, Inc. /DE/
Filed: December 30, 2019
Period of Report: December 23, 2019
Accession Number: 0001562180-19-006291

View Document ↗ View on SEC.gov ↗